Axa IM Alts invests £9bn globally in 2021

AXA IM Le Dome

AXA IM Alts has said it expects the bulk of its investment in 2022 to be in conviction asset classes such as life sciences, healthcare, residential, and industrial and logistics, as well as in repositioning offices.

The commitment was made alongside the group’s announcement that it completed €10.8bn (£9bn) of real estate equity transactions in 2021.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.

Registered users and subscribers SIGN IN here to continue